Acute migraine drug succeeds in late-stage study Acute migraine drug succeeds in late-stage study:- Eli Lilly and Co said on Friday said its acute migraine drug, lasmiditan, induced a statistically significant improvement in pain relief against a placebo in a late-stage study. The trial tested three doses of the oral […]
